Patents by Inventor Marcus B. Gohlke

Marcus B. Gohlke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100221359
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in mucosal delivery format a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 2, 2010
    Applicant: LACTOFERRIN PRODUCTS COMPANY
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Patent number: 6780438
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: August 24, 2004
    Assignee: Lactoferrin Products Company
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Publication number: 20020187200
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Application
    Filed: July 31, 2002
    Publication date: December 12, 2002
    Applicant: Lactoferrin Products Company
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Patent number: 6475511
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: November 5, 2002
    Assignee: Lactoferrin Products Company
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Patent number: 6410058
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: June 25, 2002
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Publication number: 20020054917
    Abstract: Dietary supplement compositions containing beta glucan and lactoferrin are disclosed. The compositions can be formulated as a liquid, tablet, lozenge, gum, or other acceptable forms. The compositions can further contain flavorings, carriers, or diluents. The compositions can be used in a nutritional program to enhance the activity of macrophages and neutrophils, leading to an improved ability to fight infection from bacterial, fungal, and viral challenges.
    Type: Application
    Filed: December 13, 2001
    Publication date: May 9, 2002
    Inventor: Marcus B. Gohlke
  • Publication number: 20020004073
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Application
    Filed: September 4, 2001
    Publication date: January 10, 2002
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Publication number: 20010009681
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Application
    Filed: February 6, 2001
    Publication date: July 26, 2001
    Applicant: Lactoferrin Products Company.
    Inventors: Marcus B. Gohlke, Richard H. Cockrum
  • Patent number: 6258383
    Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: July 10, 2001
    Assignee: Lactoferrin Products Company
    Inventors: Marcus B. Gohlke, Richard H. Cockrum